Value through Innovation16 January 2013

Diabetes News and Information

This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Diabetes Press Releases

back 1 2 3 4 5 6 7 8 next

07.01.2013	Boehringer Ingelheim and Eli Lilly and Company announce positive top-line pivotal Phase III data results for empagliflozin - EX US & UK. Medical Media Only.
07.01.2013	Lilly reassumes sole worldwide development and commercialization rights for novel basal insulin analog
14.11.2012	Run for diabetes: Boehringer Ingelheim supports ‘Life for a Child’ programme on World Diabetes Day
08.11.2012	Recruitment complete for Trajenta® (linagliptin) cardiovascular outcome study in patients with Type 2 Diabetes - For Non-U.S. and Non-U.K. Media
26.10.2012	European approval granted for Trajenta® (linagliptin) tablets as add-on therapy to insulin in adults with Type 2 Diabetes - For Non-U.S. and Non-U.K. Media

back 1 2 3 4 5 6 7 8 next

Further Press Releases in our Archive

Diabetes Related News Room

Resources
Videos

Diabetes Related Documents

Diabetes Video Gallery

Mode of Action of DPP-4 Inhibitors
- Watch the Video
Diabetes Complications Animation
- Watch the video
Professor Anthony Barnett: Advantages of DPP-4 inhibitors in the treatment of type 2 diabetes
- Watch the Video(WMV)
Professor Anthony Barnett: Renal impairment in type 2 diabetes
- Watch the video(WMV)
Professor Anthony Barnett: The potential of linagliptin
- Watch the video(WMV)